(BRC) Brady - Overview
Sector: Industrials | Industry: Security & Protection Services | Exchange: NYSE (USA) | Market Cap: 3.813m USD | Total Return: 26.5% in 12m
Industry Rotation: +5.3
Avg Turnover: 16.4M USD
Peers RS (IBD): 71.6
EPS Trend: 86.5%
Qual. Beats: 0
Rev. Trend: 86.0%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Brady Corporation (BRC) manufactures and supplies identification and safety products globally. The companys offerings include safety signs, labeling systems, personal protective equipment, and software for safety compliance. This business model primarily focuses on B2B sales of essential industrial and healthcare consumables.
BRC also provides materials, RFID and barcode scanners, and handheld printers for product identification and asset tracking. Additionally, it supplies wristbands, labels, and printing systems for healthcare settings, and access control solutions. The company serves diverse sectors, including industrial manufacturing, healthcare, energy, and government.
The company utilizes distributors, a direct sales force, and digital channels for product distribution. The commercial printing sector, in which BRC operates, is characterized by a need for consistent product quality and reliable supply chains to meet varied industry demands. Investors may wish to explore ValueRay for further insights into BRCs market performance and financial health.
- Industrial and safety product demand drives revenue growth
- Raw material cost fluctuations impact profit margins
- Global economic conditions influence capital expenditure
- Regulatory changes in workplace safety create new opportunities
| Net Income: 204.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA -2.42 > 1.0 |
| NWC/Revenue: 22.40% < 20% (prev 17.88%; Δ 4.52% < -1%) |
| CFO/TA 0.11 > 3% & CFO 204.9m > Net Income 204.1m |
| Net Debt (-31.6m) to EBITDA (303.6m): -0.10 < 3 |
| Current Ratio: 2.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.7m) vs 12m ago -1.18% < -2% |
| Gross Margin: 50.88% > 18% (prev 0.51%; Δ 5.04k% > 0.5%) |
| Asset Turnover: 91.94% > 50% (prev 89.41%; Δ 2.52% > 0%) |
| Interest Coverage Ratio: 61.03 > 6 (EBITDA TTM 303.6m / Interest Expense TTM 4.28m) |
| A: 0.19 (Total Current Assets 662.3m - Total Current Liabilities 310.8m) / Total Assets 1.83b |
| B: 0.77 (Retained Earnings 1.40b / Total Assets 1.83b) |
| C: 0.15 (EBIT TTM 261.0m / Avg Total Assets 1.71b) |
| D: 2.62 (Book Value of Equity 1.34b / Total Liabilities 512.2m) |
| Altman-Z'' Score: 7.54 = AAA |
| DSRI: 1.09 (Receivables 242.9m/202.0m, Revenue 1.57b/1.42b) |
| GMI: 1.00 (GM 50.88% / 50.65%) |
| AQI: 0.92 (AQ_t 0.47 / AQ_t-1 0.51) |
| SGI: 1.10 (Revenue 1.57b / 1.42b) |
| TATA: -0.00 (NI 204.1m - CFO 204.9m) / TA 1.83b) |
| Beneish M-Score: -2.93 (Cap -4..+1) = A |
Over the past week, the price has changed by +4.73%, over one month by -3.25%, over three months by +1.65% and over the past year by +26.51%.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 101 | 20.6% |
P/E Forward = 15.361
P/S = 2.4296
P/B = 2.9038
P/EG = 1.6733
Revenue TTM = 1.57b USD
EBIT TTM = 261.0m USD
EBITDA TTM = 303.6m USD
Long Term Debt = 78.7m USD (from longTermDebt, last quarter)
Short Term Debt = 17.5m USD (from shortTermDebt, last quarter)
Debt = 144.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -31.6m USD (from netDebt column, last quarter)
Enterprise Value = 3.78b USD (3.81b + Debt 144.9m - CCE 176.5m)
Interest Coverage Ratio = 61.03 (Ebit TTM 261.0m / Interest Expense TTM 4.28m)
EV/FCF = 22.27x (Enterprise Value 3.78b / FCF TTM 169.8m)
FCF Yield = 4.49% (FCF TTM 169.8m / Enterprise Value 3.78b)
FCF Margin = 10.82% (FCF TTM 169.8m / Revenue TTM 1.57b)
Net Margin = 13.01% (Net Income TTM 204.1m / Revenue TTM 1.57b)
Gross Margin = 50.88% ((Revenue TTM 1.57b - Cost of Revenue TTM 770.8m) / Revenue TTM)
Gross Margin QoQ = 50.61% (prev 51.53%)
Tobins Q-Ratio = 2.07 (Enterprise Value 3.78b / Total Assets 1.83b)
Interest Expense / Debt = 0.68% (Interest Expense 990k / Debt 144.9m)
Taxrate = 22.50% (14.0m / 62.0m)
NOPAT = 202.3m (EBIT 261.0m * (1 - 22.50%))
Current Ratio = 2.13 (Total Current Assets 662.3m / Total Current Liabilities 310.8m)
Debt / Equity = 0.11 (Debt 144.9m / totalStockholderEquity, last quarter 1.31b)
Debt / EBITDA = -0.10 (Net Debt -31.6m / EBITDA 303.6m)
Debt / FCF = -0.19 (Net Debt -31.6m / FCF TTM 169.8m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.96% (Net Income 204.1m / Total Assets 1.83b)
RoE = 16.60% (Net Income TTM 204.1m / Total Stockholder Equity 1.23b)
RoCE = 19.95% (EBIT 261.0m / Capital Employed (Equity 1.23b + L.T.Debt 78.7m))
RoIC = 15.22% (NOPAT 202.3m / Invested Capital 1.33b)
WACC = 7.98% (E(3.81b)/V(3.96b) * Re(8.26%) + D(144.9m)/V(3.96b) * Rd(0.68%) * (1-Tc(0.23)))
Discount Rate = 8.26% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.50%
[DCF] Terminal Value 79.65% ; FCFF base≈176.4m ; Y1≈190.7m ; Y5≈236.7m
[DCF] Fair Price = 96.64 (EV 4.19b - Net Debt -31.6m = Equity 4.22b / Shares 43.7m; r=7.98% [WACC]; 5y FCF grow 9.22% → 3.0% )
EPS Correlation: 86.53 | EPS CAGR: 9.33% | SUE: 0.0 | # QB: 0
Revenue Correlation: 86.00 | Revenue CAGR: 3.43% | SUE: 0.55 | # QB: 0
EPS current Year (2026-07-31): EPS=5.04 | Chg7d=+0.000 | Chg30d=-0.005 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+6.4%
EPS next Year (2027-07-31): EPS=5.47 | Chg7d=+0.000 | Chg30d=-0.035 | Revisions Net=-1 | Growth EPS=+8.5% | Growth Revenue=+3.5%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.0% (Discount Rate 8.3% - Earnings Yield 5.3%)
[Growth] Growth Spread = +0.5% (Analyst 3.5% - Implied 3.0%)